These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20455254)

  • 21. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling pathway used by HSV-1 to induce NF-kappaB activation: possible role of herpes virus entry receptor A.
    Teresa Sciortino M; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè M; Venuti A; Grelli S; Mastino A
    Ann N Y Acad Sci; 2007 Jan; 1096():89-96. PubMed ID: 17405920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
    Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
    Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
    Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of herpes simplex virus genital infection: comparison of a multiplex PCR assay and traditional viral isolation techniques.
    Marshall DS; Linfert DR; Draghi A; McCarter YS; Tsongalis GJ
    Mod Pathol; 2001 Mar; 14(3):152-6. PubMed ID: 11266519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
    Andreansky S; Soroceanu L; Flotte ER; Chou J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
    Cancer Res; 1997 Apr; 57(8):1502-9. PubMed ID: 9108452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Herpes simplex virus and malignancies of female genital organs].
    Cokić-Damjanović J; Horvat E; Balog A
    Med Pregl; 2001; 54(9-10):432-7. PubMed ID: 11876004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.
    Sciortino MT; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè-Cuculletto M; Venuti A; Grelli S; Mastino A
    Cell Microbiol; 2008 Nov; 10(11):2297-311. PubMed ID: 18671825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
    Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
    Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Three cases of herpes simplex virus type 2 myelitis--detection of HSV2 DNA in cerebrospinal fluid].
    Nakajima H; Furutama D; Shinoda K; Ohsawa N; Nakagawa T
    Rinsho Shinkeigaku; 1993 Jul; 33(7):715-20. PubMed ID: 8252822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods].
    Akçali A; Ozkaya E; Yilmaz D; Uyar Y; Oncül O
    Mikrobiyol Bul; 2008 Jul; 42(3):421-8. PubMed ID: 18822885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.
    Warner MS; Geraghty RJ; Martinez WM; Montgomery RI; Whitbeck JC; Xu R; Eisenberg RJ; Cohen GH; Spear PG
    Virology; 1998 Jun; 246(1):179-89. PubMed ID: 9657005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.
    Linehan MM; Richman S; Krummenacher C; Eisenberg RJ; Cohen GH; Iwasaki A
    J Virol; 2004 Mar; 78(5):2530-6. PubMed ID: 14963155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues.
    Adamson LA; Fowler LJ; Ewald AS; Clare-Salzler MJ; Hobbs JA
    J Med Virol; 2014 Sep; 86(9):1614-20. PubMed ID: 24265024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mimicking herpes simplex virus 1 and herpes simplex virus 2 mucosal behavior in a well-characterized human genital organ culture.
    Steukers L; Weyers S; Yang X; Vandekerckhove AP; Glorieux S; Cornelissen M; Van den Broeck W; Temmerman M; Nauwynck HJ
    J Infect Dis; 2014 Jul; 210(2):209-13. PubMed ID: 24436451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.
    Chen CH; Chen WY; Lin SF; Wong RJ
    Hum Gene Ther; 2014 Jun; 25(6):539-51. PubMed ID: 24568312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions.
    Giaginis C; Zarros A; Alexandrou P; Klijanienko J; Delladetsima I; Theocharis S
    APMIS; 2010 Mar; 118(3):210-21. PubMed ID: 20132187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of nectin-1 in normal and herpes simplex virus type 1-infected murine brain.
    Shukla D; Scanlan PM; Tiwari V; Sheth V; Clement C; Guzman-Hartman G; Dermody TS; Valyi-Nagy T
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):341-7. PubMed ID: 16932027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.
    Wang PY; Currier MA; Hansford L; Kaplan D; Chiocca EA; Uchida H; Goins WF; Cohen JB; Glorioso JC; van Kuppevelt TH; Mo X; Cripe TP
    Gene Ther; 2013 Jul; 20(7):761-9. PubMed ID: 23254370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSV usurps eukaryotic initiation factor 3 subunit M for viral protein translation: novel prevention target.
    Cheshenko N; Trepanier JB; Segarra TJ; Fuller AO; Herold BC
    PLoS One; 2010 Jul; 5(7):e11829. PubMed ID: 20676407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.